Rocket


Overview
Financials
News + Filings

 
 

Aerovate Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsMar-31-21Dec-31-20Mar-31-20Dec-31-19
Revenues7.9 3.1 
            Revenue growth155.1%   
Cost of goods sold15.9 6.2 
Gross profit-7.9 -3.1 
            Gross margin-100.0% -100.0% 
General and administrative0.9 0.2 
EBIT-8.9 -3.3 
            EBIT margin-112.0% -107.0% 
Pre-tax income0.0 0.0 
Income taxes0.0 0.0 
Net income0.0 0.0 
            Net margin0.0% 0.0% 
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy